Indications

• Age-Related Macular Degeneration (AMD)
• Eye Health
• Cataracts
• Eye Fatigue

Ingredients

Serving Size: 2 Softgels... ... %DV
Lutein... 15 mg... †
Zeaxanthin... 15 mg... †
Benfotiamine... 160 mg... †
Astaxanthin... 4 mg... †
Black Soybean hull extract... 120 mg... †
(10% Cyanidin-3-Glucosides)
† Daily Value not established

Description

What Is It?
Vision Support II is a combination of the most advanced nutraceuticals clinically demonstrated to help support eye health. AOR's Vision Support II provides lutein, zeaxanthin, astaxanthin, benfotiamine and black soybean hull extract in an olive oil suspension which enhances the effectiveness of certain ingredients. The effectiveness of Vision Support II can be maximized with a complete, high-quality multivitamin/mineral formulation.

What Does It Do?
Primary Uses: Vision Support II is primarily designed to protect against age-related macular degeneration (AMD), and can also protect against the development of cataracts. Ultraviolet light and blue light contribute to damage in the lens and macula. Lutein and zeaxanthin are pigments found in the eyes whose main function is the filtration of UV light. Benfotiamine is a highly bioavailable form of vitamin B1. Studies have shown that benfotiamine helps prevent the formation of AGEs (advanced glycation end-products), damaged proteins that accumulate in the lens and can result in cataracts. Astaxanthin, a carotenoid found in algae, and black soybean hull rich in the anthocyanin cyanidin-3-glucoside (C3G) have been shown to clinically reduce eye fatigue related to extended exposure to computer screens.

Who Should Take It?
Vision Support II is especially beneficial for those with a family history of macular degeneration, for active people who spend a lot of time outside in the sun, and for those who spend a good amount of time on computers such as office workers or students.

Quantity

60 Softgels

Dose

Take 2 softgels daily with food, or as directed by a qualified health care practitioner.

Potential side effects/Safety

321

References

"Show references"

"Hide references"

Bone RA, et al. J Nutr. Anthocyanosides in the treatment of retinopathies. Erratum in: J Nutr. 2003 Jun;133(6):1953.

Nagaki Y, et al. Effects of Astaxanthin on accommodation, critical flicker fusions, and pattern evoked potential in visual display terminal workers. (2002). J. Trad. Med., 19(5): 170-173.

Sakimoto T, et al. Clinical study with black soybean extract on ocular function. Japanese Review of Clinical Ophthalmology. V.98;N.11;Pg.982-986 (2004).